These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37234179)

  • 1. Correlation of Wilms' Tumor 1 (WT1) with Oxidative Stress Markers and Expression of miR-361-5p; New Aspect of WT1 in Breast Cancer.
    Pishbin F; Ziamajidi N; Abbasalipourkabir R; Najafi R; Farhadian M
    Indian J Clin Biochem; 2023 Jul; 38(3):338-350. PubMed ID: 37234179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p.
    Li X; An W; Pan H; Fan Y; Huang H; Wang Y; Shen W; Zu L; Meng F; Zhou X
    BMC Cancer; 2023 Sep; 23(1):824. PubMed ID: 37667197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
    Xie F; Hosany S; Zhong S; Jiang Y; Zhang F; Lin L; Wang X; Gao S; Hu X
    PLoS One; 2017; 12(10):e0185565. PubMed ID: 29016617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis.
    Fu D; Ji Q; Wang C; Yu L; Yu R
    Cell Cycle; 2021 Dec; 20(23):2476-2493. PubMed ID: 34720052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
    Dai SG; Guo LL; Xia X; Pan Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):486-495. PubMed ID: 30720155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of lncRNA WT1-AS ameliorates Aβ-stimulated neuronal injury through modulation of miR-186-5p/CCND2 axis in Alzheimer's disease.
    Tang Y; Zhang X; Wang S; Liu L; Wang Q; Liu Y; Yu Y; Zhai Q
    Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):200-206. PubMed ID: 38372094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer.
    Pishbin F; Ziamajidi N; Abbasalipourkabir R; Najafi R; Farhadian M
    Per Med; 2021 Jan; 18(1):31-42. PubMed ID: 33393369
    [No Abstract]   [Full Text] [Related]  

  • 8. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225-5p/WT1 axis to regulate non-small cell lung cancer cell malignant behavior.
    Zhu X; Wan J; You X; Yang W; Zhao L
    Thorac Cancer; 2023 Jul; 14(20):1969-1979. PubMed ID: 37220935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-27a-5p Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis of Wilms' Tumor Cell by Targeting PBOV1.
    Guo ZT; Yu Q; Miao C; Ge W; Li P
    Mol Cell Biol; 2022 Aug; 42(8):e0039721. PubMed ID: 35862727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-361-5p suppresses the tumorigenesis of hepatocellular carcinoma through targeting WT1 and suppressing WNT/β-cadherin pathway.
    Cheng Y; Qiu L; He GL; Cai L; Peng BJ; Cao YL; Pan MX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8823-8832. PubMed ID: 31696469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The miR-143/145 cluster induced by TGF-β1 suppresses Wilms' tumor 1 expression in cultured human podocytes.
    Tabei A; Sakairi T; Hamatani H; Ohishi Y; Watanabe M; Nakasatomi M; Ikeuchi H; Kaneko Y; Kopp JB; Hiromura K
    Am J Physiol Renal Physiol; 2023 Jul; 325(1):F121-F133. PubMed ID: 37167274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin attenuates Adriamycin-resistance of acute myeloid leukemia by inhibiting the lncRNA HOTAIR/miR-20a-5p/WT1 axis.
    Liu JM; Li M; Luo W; Sun HB
    Lab Invest; 2021 Oct; 101(10):1308-1317. PubMed ID: 34282279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-199a-5p stimulates ovarian granulosa cell apoptosis in polycystic ovary syndrome.
    Shao S; Wang H; Shao W; Liu N
    J Mol Endocrinol; 2020 Nov; 65(4):187-201. PubMed ID: 33095185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
    Wu ZS; Wu Q; Wang CQ; Wang XN; Wang Y; Zhao JJ; Mao SS; Zhang GH; Zhang N; Xu XC
    BMC Cancer; 2010 Oct; 10():542. PubMed ID: 20932331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer.
    Beveridge DJ; Richardson KL; Epis MR; Brown RAM; Stuart LM; Woo AJ; Leedman PJ
    Sci Rep; 2021 Sep; 11(1):18003. PubMed ID: 34504167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell via regulating p53 expression via sponging miR-330-5p.
    Cui L; Nai M; Zhang K; Li L; Li R
    Cancer Manag Res; 2019; 11():651-667. PubMed ID: 30666161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Intricate Relationship Between miR-155-5p Expression and Oxidative Stress in Bladder Cancer Patients Treated with Calmette-Guerin Immunotherapy.
    Darzi MM; Neamati N; Sadeghi F; Bijani A; Moudi E
    Int J Mol Cell Med; 2024; 13(2):186-197. PubMed ID: 39184817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.